Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 23242284)

1.

Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies.

Mukaetova-Ladinska EB, Andras A, Milne J, Abdel-All Z, Borr I, Jaros E, Perry RH, Honer WG, Cleghorn A, Doherty J, McIntosh G, Perry EK, Kalaria RN, McKeith IG.

J Neuropathol Exp Neurol. 2013 Jan;72(1):53-60. doi: 10.1097/NEN.0b013e31827c5710.

PMID:
23242284
2.

Lewy body variant of Alzheimer's disease: selective neocortical loss of t-SNARE proteins and loss of MAP2 and alpha-synuclein in medial temporal lobe.

Mukaetova-Ladinska EB, Xuereb JH, Garcia-Sierra F, Hurt J, Gertz HJ, Hills R, Brayne C, Huppert FA, Paykel ES, McGee MA, Jakes R, Honer WG, Harrington CR, Wischik CM.

ScientificWorldJournal. 2009 Dec 16;9:1463-75. doi: 10.1100/tsw.2009.151.

3.

Synaptic pathology in prefrontal cortex is present only with severe dementia in Alzheimer disease.

Minger SL, Honer WG, Esiri MM, McDonald B, Keene J, Nicoll JA, Carter J, Hope T, Francis PT.

J Neuropathol Exp Neurol. 2001 Oct;60(10):929-36.

PMID:
11589423
4.

Dementia with Lewy bodies: choline acetyltransferase parallels nucleus basalis pathology.

Lippa CF, Smith TW, Perry E.

J Neural Transm. 1999;106(5-6):525-35.

PMID:
10443555
5.

Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.

Higuchi M, Tashiro M, Arai H, Okamura N, Hara S, Higuchi S, Itoh M, Shin RW, Trojanowski JQ, Sasaki H.

Exp Neurol. 2000 Apr;162(2):247-56.

PMID:
10739631
6.

Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies.

Fujishiro H, Umegaki H, Isojima D, Akatsu H, Iguchi A, Kosaka K.

Acta Neuropathol. 2006 Feb;111(2):109-14. Epub 2006 Jan 19.

PMID:
16421740
7.

Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB).

Imamura T, Ishii K, Hirono N, Hashimoto M, Tanimukai S, Kazuai H, Hanihara T, Sasaki M, Mori E.

Neuroreport. 1999 Jun 23;10(9):1903-7.

PMID:
10501530
8.

Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease.

Tiraboschi P, Hansen LA, Alford M, Merdes A, Masliah E, Thal LJ, Corey-Bloom J.

Arch Gen Psychiatry. 2002 Oct;59(10):946-51.

PMID:
12365882
9.

Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies.

Kasanuki K, Iseki E, Fujishiro H, Yamamoto R, Higashi S, Minegishi M, Togo T, Katsuse O, Uchikado H, Furukawa Y, Hino H, Kosaka K, Sato K, Arai H.

J Neurol Sci. 2012 Mar 15;314(1-2):111-9. doi: 10.1016/j.jns.2011.10.010. Epub 2011 Oct 30.

PMID:
22041339
10.

Nicotinic receptor losses in dementia with Lewy bodies: comparisons with Alzheimer's disease.

Rei RT, Sabbagh MN, Corey-Bloom J, Tiraboschi P, Thal LJ.

Neurobiol Aging. 2000 Sep-Oct;21(5):741-6.

PMID:
11016544
11.

Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies.

Campbell BC, Li QX, Culvenor JG, Jäkälä P, Cappai R, Beyreuther K, Masters CL, McLean CA.

Neurobiol Dis. 2000 Jun;7(3):192-200.

PMID:
10860784
12.

Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies.

Muntané G, Dalfó E, Martinez A, Ferrer I.

Neuroscience. 2008 Apr 9;152(4):913-23. doi: 10.1016/j.neuroscience.2008.01.030. Epub 2008 Feb 5.

PMID:
18343584
13.

Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.

Marui W, Iseki E, Kato M, Akatsu H, Kosaka K.

Acta Neuropathol. 2004 Aug;108(2):121-8. Epub 2004 May 14.

PMID:
15235805
14.

Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies.

Deramecourt V, Bombois S, Maurage CA, Ghestem A, Drobecq H, Vanmechelen E, Lebert F, Pasquier F, Delacourte A.

J Neuropathol Exp Neurol. 2006 Mar;65(3):278-88.

PMID:
16651889
15.

Neuritic pathology as a correlate of synaptic loss in dementia with lewy bodies.

Revuelta GJ, Rosso A, Lippa CF.

Am J Alzheimers Dis Other Demen. 2008 Feb-Mar;23(1):97-102. doi: 10.1177/1533317507310565.

PMID:
18276962
16.

Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.

Harding AJ, Broe GA, Halliday GM.

Brain. 2002 Feb;125(Pt 2):391-403.

17.

Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.

Klucken J, Ingelsson M, Shin Y, Irizarry MC, Hedley-Whyte ET, Frosch M, Growdon J, McLean P, Hyman BT.

Acta Neuropathol. 2006 Feb;111(2):101-8. Epub 2006 Feb 16.

PMID:
16482476
18.

Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.

Obi K, Akiyama H, Kondo H, Shimomura Y, Hasegawa M, Iwatsubo T, Mizuno Y, Mochizuki H.

Exp Neurol. 2008 Apr;210(2):409-20. doi: 10.1016/j.expneurol.2007.11.019. Epub 2007 Dec 3.

PMID:
18164295
19.

Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density.

Samuel W, Alford M, Hofstetter CR, Hansen L.

J Neuropathol Exp Neurol. 1997 May;56(5):499-508.

PMID:
9143263
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk